DEF 14A

Company

Aprea Therapeutics, Inc.

Filed

June 10, 2022

Period of Report

July 28, 2022

Accession Number

0001558370-22-009946

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →